Navigation Links
Dr. Ritchie Shoemaker Proudly Announces First Graduate of Shoemaker Protocol Certification Training
Date:4/4/2013

Pokomoke, MD (PRWEB) April 04, 2013

Leading biotoxin and mold illness expert Dr. Ritchie Shoemaker has recently developed a training and certification program that enables doctors to provide patients with the latest and most effective treatment for patients suffering from Chronic Inflammatory Response Syndrome (CIRS). Now, Dr. Scott McMahon, of Roswell, New Mexico, has become the first Shoemaker Protocol Certified Physician.

“We are extremely proud to be able to announce such a major accomplishment by Dr. McMahon,” wrote Dr. Shoemaker in a recent newsletter. “There is currently no board certification covering this disease [CIRS]. The closest to such an achievement is passing this CIRS Certification Program, and Dr. McMahon is the first physician in the world to have completed this rigorous testing.”

Scott W. McMahon, MD, completed his Bachelors of Science degree in Chemistry from Creighton University in 1985, and went on to complete his Medical Degree at Creighton University School of Medicine in 1989. After completing a prestigious pediatric residency at Duke University Medical Center, he has maintained board certification and practiced pediatrics in Roswell, New Mexico for 20 years. His interest in Chronic Inflammatory Response Syndrome began in 2009.

Dr. McMahon has spoken on CIRS and other topics at a number of medical meetings. He has written two books and co-authored two position statements. One statement, co-authored by Dr. Shoemaker and other experts, is the most comprehensive paper to date on CIRS and the health effects of exposure to the interior of water-damaged buildings. Dr. McMahon has participated in two “mold” trials. He maintains an office for CIRS patients in Roswell and another in Albuquerque, New Mexico.

Dr. Shoemaker continued “We anticipate many more doctors coming on line in the near term and will announce them as they complete their certification. Surviving Mold is diligently working to get certified physicians throughout the country. We are so pleased to have a doctor in the southwestern United States, so we can affirmatively answer the tens of thousands that visit our site each month, ‘Yes, we do have a doctor in your area that practices the Shoemaker Protocol!’”.

Ritchie Shoemaker, MD, is an internationally recognized leader in education, patient care, and research in the field of biotoxin related illness, and has treated over 6,000 patients. Dr. Shoemaker has written numerous papers and eight books, including the widely read Surviving Mold, and Mold Warriors. He has appeared on Good Morning America, the BBC, the Australian Broadcasting System, the Discovery Health Channel, and has spoken to the House of Representatives and the US Senate. He continues to give lectures, attend conferences on biotoxin illness, and provide one on one training to physicians working toward the Shoemaker CIRS Protocol Certification.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10588737.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Health Heroes and DMG Productions Proudly Announce Airing of New Episodes
2. The Scientist Proudly Announces the Top 10 Innovations of 2012
3. Aveka Nutra Processing proudly begins producing products from Z Trim Holdings, Inc.
4. irisnote Announces Successful Conclusion of Beta Test Phase
5. American Federation for Aging Research Announces Recipients of Irving S. Wright and Vincent Cristofalo Scientific Awards
6. PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
7. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
8. Burns Engineering Announces Expanded Selection of Miniature Temperature Sensors
9. LabRoots Announces New Cell Biology Image Contest
10. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
11. MGC Diagnostics Corporation Announces Special Cash Dividend and Extension of Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)...  Bayer today announced that a Phase III ... (regorafenib) tablets for the treatment of patients with ... endpoint of a statistically significant improvement in overall ... and safety of regorafenib in patients with HCC ... The safety and tolerability were generally consistent with ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... recent innovations in biotechnology to help treat hormonal and stress related hair loss. ... has captured the hearts of key opinion leaders in the medical and salon ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... at Boston CEO 2016 on May 31st and June 1st at The Four ... for leading executives in the life sciences, offering exclusive access to key decision ...
(Date:5/3/2016)... 2016 - And Other Rising ... of Those Competitor Biologics  - Biosimilar Drug ... Prospects ,  Who are the most important ... are their sales potentials? Discover, in our updated survey, ... opportunities and revenue forecasting. Visiongain,s ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):